Navigation Links
Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
Date:11/10/2008

amination data, electrophysiological testing data, subject neurological questionnaire, and subject pain assessment. Specifically, investigators used the following tests: the visual analog scale for pain intensity (VASPI), a modified Neuropathy Impairment Score -- Lower Limbs (NIS-LL) scoring system as well as total neuropathy score (TNS) to assess signs and symptoms of the condition. In addition, data from electrophysiological testing using nerve conduction velocity (NCV) to assess the rate at which a nerve can conduct an electrical signal, and quantitative sensory testing (QST) with the Vibratron II instrument, to assess the threshold of detection of vibration were also collected. Skin biopsies were taken to evaluate the direct therapeutic effect of SB-509 on nerve regrowth.

About Diabetic Neuropathy

Diabetic peripheral neuropathy is one of the most frequent complications of diabetes. Symptoms include numbness, tingling sensations and pain particularly in the toes or feet. This gradually evolves to loss of sensation and motor function as nerve damage progresses. Ulcers and sores may appear on numb areas of the foot because pressure or injury goes unnoticed. Despite adequate treatment, these areas of trauma frequently become infected and this infection may spread to the bone, necessitating amputation of the leg or foot. More than 60 percent of non-traumatic lower-limb amputations in the United States occur among people with diabetes. In 2004, this translated to approximately 71,000 amputations. Diabetes is a growing problem, the Centers for Disease Control estimates that from 1980 through 2007, the number of Americans with diabetes increased from 5.6 million to 23.6 million and that of those about 60 percent to 70 percent have mild to severe forms of neuropathy.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advance
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
2. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
3. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
4. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
5. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
6. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
8. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
9. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
10. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
11. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Biotechnology industry pioneer Amgen ... software provider BlackLine Systems  and enterprise application software ... for a webinar next week entitled "No Account Left ... and SAP to Help Keep Its Account Reconciliations in Good ... The webinar, geared at finance, accounting, audit ...
(Date:6/19/2013)... June 19, 2013 India’s vast ... can potentially be worth up to a billion ... the Indian government is taking serious action to ... process. , This presentation will examine:, ... ,     Immediate and long term impacts , ...
(Date:6/19/2013)... Earth, MN (PRWEB) June 19, 2013 ... of abuse tests, today announced that it has received ... to market and sell its DrugCheck® NxStep Onsite ... allows use of the rapid screening device in near-patient ... Onsite Drug Screen Cup received Health Canada Class III ...
(Date:6/18/2013)... A million electric cars could be on roads across ... help of research by the United States Department of Energy, ... Professor Zhongwei Chen is part of a team led by ... to replace the expensive platinum catalysts in fuel cells. , ... cells in vehicles is the cost of the units. The ...
Breaking Biology Technology:Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2
... The firm's shares shot up 40% this morning after it ... drug in the company's pipeline, has been found to extend ... ,Late last week, new data and a regulatory decision buttressed ... - news - people ) is developing ...
... (WMC), Valhalla, New York, has selected Verisis developed by ... Corporation , for its new Cardiology Image and Information Management ... George E. Reed Heart Center , one of the ... east coast. The system will also extend into the ...
... of streaming media was predominantly targeted toward consumer applications ... money hasn't followed. The focus on streaming media is ... that can improve productivity and the information experience. Just ... educational institutions are beginning to see the value of ...
Cached Biology Technology:Genentech's Winning Streak 2Genentech's Winning Streak 3NY Medical Center Selects Camtronics for Cardiovascular Image and Information Management 2
(Date:6/19/2013)... of the patients who received injections of steroids ... New England Compounding Center has found that some ... not experience a worsening of their symptoms and ... infection, especially among those individuals who received injections ... along with an editorial by UC Davis Assistant ...
(Date:6/19/2013)... 2013 A study published in the Journal ... report of an oral probiotic supplement significantly increasing circulating ... The lead author on the study, Mitchell Jones, MD, ... from the New York Academy of Sciences and the ... Prebiotics, and the Host Microbiome: The Science of ...
(Date:6/19/2013)... Flemish plant scientist Marc Van Montagu (born 1933) is ... the American scientists Mary-Dell Chilton and Robert T. Fraley. ... the US Secretary of State, John Kerry. The World ... agriculture" - gives the award annually to one or ... importance for the quality, quantity or availability of food. ...
Breaking Biology News(10 mins):Evolution of an outbreak: Complications from contaminated steroid injections 2Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4
... A specific biological response to cellular stress may predict ... common, non-invasive form of pre-malignant breast cancer-- ductal carcinoma ... could potentially be used in a clinical setting to ... therapy when initially diagnosed with DCIS, according to a ...
... Using an extremely sensitive measurement technique, researchers at ... a lead-specific DNAzyme uses the lock and key reaction ... the same DNAzyme uses the induced fit reaction ... and key mechanism explains why this particular lead-specific DNAzyme ...
... a new vaccine be the key to stopping Alzheimers ... Research Foundation (OMRF) shows that immunization could offer a ... disease. OMRF scientists immunized Alzheimers mice with a ... disease-causing process. The mice who received the vaccination showed ...
Cached Biology News:Cell response to stress signals predicts tumors in women with common pre-breast cancer 2Cell response to stress signals predicts tumors in women with common pre-breast cancer 3The key to unlocking the secret of highly specific DNAzyme catalysis 2An Alzheimer's vaccine? 2An Alzheimer's vaccine? 3
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
Anti-human C5a/C5a des-Arg (neo-epitode), Clone 2952, Monoclonal Antibody...
...
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Biology Products: